1Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
2Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania
3Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania
4Nephrology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
5Harvard Medical School, Boston, Massachusetts
6Office of the Chief Medical Officer, Brigham and Women's Hospital, Boston, Massachusetts
Correspondence: Dr. Yuvaram N.V. Reddy, 3400 Spruce Street, Renal Offices, 1 Founders, Renal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA 19104. Email: [email protected]
Published online ahead of print. Publication date available at www.cjasn.org.
See related article, “Mortality Risk of Patients Treated in Dialysis Facilities with Payment Reductions under ESRD Quality Incentive Program,” on pages 356–362.
